SIRT6 and colonic neoplasm: On the other hand, SIRT6 also serves as a negative regulator of lipid metabolism [281], with the EGF-dependent down-regulation of SIRT6 (FOXO3/SIRT6) resulting in enhanced LD biogenesis in human colon cancer cells [282].